Payment overview · 2025
General Payments
$13.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
James Stanley Sinclair, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · DOUGLAS, GA · NPI 1437142320
Verified facts
What the public records show
CMS Open Payments records show James Stanley Sinclair, M.D. received $13.96 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 66 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 255 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $13.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $13.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 255 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
66 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
255 | 11 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 2711 | 345 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 2107 | 84 |
| Potassium Chloride | Potassium Chloride | 1943 | 114 |
| Gabapentin | Gabapentin | 1917 | 101 |
| Furosemide | Furosemide | 1821 | 113 |
| Omeprazole | Omeprazole | 1788 | 136 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1737 | 110 |
| Eliquis | Apixaban | 1545 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 1544 | 103 |
| Famotidine | Famotidine | 1484 | 69 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1433 | 66 |
| Sertraline Hcl | Sertraline Hcl | 1288 | 50 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1261 | 102 |
| Lisinopril | Lisinopril | 1257 | 77 |
| Donepezil Hcl | Donepezil Hcl | 1036 | 51 |
| Mirtazapine | Mirtazapine | 1028 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1008 | 81 |
| Carvedilol | Carvedilol | 989 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 987 | 59 |
| Allopurinol | Allopurinol | 968 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 893 | 84 |
| Quetiapine Fumarate | Quetiapine Fumarate | 874 | 49 |
| Buspirone Hcl | Buspirone Hcl | 868 | 48 |
| Pravastatin Sodium | Pravastatin Sodium | 866 | 49 |
| Memantine Hcl | Memantine Hcl | 826 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 781 | 54 |
| Losartan Potassium | Losartan Potassium | 749 | 44 |
| Trazodone Hcl | Trazodone Hcl | 726 | 41 |
| Metformin Hcl | Metformin Hcl | 677 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 650 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 617 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 596 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 583 | 35 |
| Valsartan | Valsartan | 560 | 38 |
| Alprazolam | Alprazolam | 555 | 87 |
| Divalproex Sodium | Divalproex Sodium | 544 | 31 |
| Spironolactone | Spironolactone | 525 | 37 |
| Montelukast Sodium | Montelukast Sodium | 518 | 33 |
| Risperidone | Risperidone | 518 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 510 | 26 |
| Levetiracetam | Levetiracetam | 465 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 454 | 19 |
| Jardiance | Empagliflozin | 429 | 26 |
| Sucralfate | Sucralfate | 429 | 23 |
| Tramadol Hcl | Tramadol Hcl | 414 | 118 |
| Zolpidem Tartrate | Zolpidem Tartrate | 402 | 58 |
| Citalopram Hbr | Citalopram Hydrobromide | 397 | 22 |
| Nifedipine Er | Nifedipine | 391 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 388 | 57 |
| Pregabalin | Pregabalin | 338 | 62 |
| Januvia | Sitagliptin Phosphate | 308 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 292 | 14 |
| Clonazepam | Clonazepam | 260 | 41 |
| Fluoxetine Hcl | Fluoxetine Hcl | 259 | 15 |
| Farxiga | Dapagliflozin Propanediol | 255 | 11 |
| Meloxicam | Meloxicam | 251 | 29 |
| Xarelto | Rivaroxaban | 242 | 16 |
| Aripiprazole | Aripiprazole | 221 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 220 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 218 | 24 |
| Finasteride | Finasteride | 218 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 216 | 15 |
| Olanzapine | Olanzapine | 212 | 22 |
| Baclofen | Baclofen | 209 | 13 |
| Bupropion Xl | Bupropion Hcl | 208 | suppressed |
| Tradjenta | Linagliptin | 200 | 13 |
| Doxepin Hcl | Doxepin Hcl | 196 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 195 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 195 | 28 |
| Bupropion Hcl | Bupropion Hcl | 191 | suppressed |
| Bumetanide | Bumetanide | 188 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 187 | suppressed |
| Lorazepam | Lorazepam | 186 | 36 |
| Clonidine Hcl | Clonidine Hcl | 183 | 23 |
| Ezetimibe | Ezetimibe | 183 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 175 | 46 |
| Glimepiride | Glimepiride | 160 | 15 |
| Ziprasidone Hcl | Ziprasidone Hcl | 151 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 150 | 39 |
| Myrbetriq | Mirabegron | 145 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 144 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 142 | 16 |
| Topiramate | Topiramate | 138 | 13 |
| Midodrine Hcl | Midodrine Hcl | 131 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 131 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 128 | 35 |
| Pentoxifylline | Pentoxifylline | 122 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 121 | 42 |
| Oxycodone Hcl | Oxycodone Hcl | 121 | 26 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 117 | 11 |
| Latanoprost | Latanoprost | 116 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 116 | 20 |
| Calcitriol | Calcitriol | 114 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 113 | suppressed |
| Trulicity | Dulaglutide | 111 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 110 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 105 | 18 |
| Glipizide | Glipizide | 105 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 104 | suppressed |
| Febuxostat | Febuxostat | 99 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 96 | 17 |
| Lamotrigine | Lamotrigine | 95 | suppressed |
| Linzess | Linaclotide | 95 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 93 | 46 |
| Haloperidol | Haloperidol | 92 | suppressed |
| Rayaldee | Calcifediol | 89 | suppressed |
| Entresto | Sacubitril/Valsartan | 87 | 15 |
| Oxcarbazepine | Oxcarbazepine | 85 | suppressed |
| Cilostazol | Cilostazol | 84 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 81 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 77 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 76 | suppressed |
| Metolazone | Metolazone | 76 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 75 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 73 | 22 |
| Divalproex Sodium Er | Divalproex Sodium | 71 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 71 | suppressed |
| Gemtesa | Vibegron | 70 | suppressed |
| Primidone | Primidone | 70 | suppressed |
| Cephalexin | Cephalexin | 69 | 37 |
| Rivastigmine | Rivastigmine Tartrate | 68 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 67 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 67 | 42 |
| Novolin R Flexpen | Insulin Regular, Human | 67 | 14 |
| Vascepa | Icosapent Ethyl | 67 | suppressed |
| Brilinta | Ticagrelor | 66 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 66 | 14 |
| Levofloxacin | Levofloxacin | 65 | 43 |
| Testosterone Cypionate | Testosterone Cypionate | 65 | 19 |
| Ertapenem | Ertapenem Sodium | 64 | 12 |
| Prednisone | Prednisone | 64 | 30 |
| Memantine Hcl Er | Memantine Hcl | 62 | suppressed |
| Chlorthalidone | Chlorthalidone | 61 | suppressed |
| Digoxin | Digoxin | 60 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 60 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 24 |
| Fluconazole | Fluconazole | 59 | 36 |
| Clindamycin Hcl | Clindamycin Hcl | 58 | 36 |
| Rexulti | Brexpiprazole | 58 | suppressed |
| Lactulose | Lactulose | 57 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 57 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 55 | suppressed |
| Ondansetron Odt | Ondansetron | 55 | 30 |
| Azithromycin | Azithromycin | 54 | 41 |
| Eszopiclone | Eszopiclone | 54 | suppressed |
| Levemir Flexpen | Insulin Detemir | 54 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 53 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 53 | suppressed |
| Novolog Flexpen | Insulin Aspart | 53 | 11 |
| Budesonide | Budesonide | 52 | 13 |
| Fosinopril Sodium | Fosinopril Sodium | 52 | suppressed |
| Probenecid | Probenecid | 52 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 52 | 24 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 39 |
| Simvastatin | Simvastatin | 51 | 14 |
| Lidocaine | Lidocaine | 50 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 50 | suppressed |
| Rivastigmine | Rivastigmine | 50 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 49 | 49 |
| Cholestyramine | Cholestyramine (With Sugar) | 49 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 49 | suppressed |
| Mounjaro | Tirzepatide | 49 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 49 | suppressed |
| Sotalol | Sotalol Hcl | 49 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 49 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 48 | 23 |
| Lithium Carbonate | Lithium Carbonate | 48 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 47 | 32 |
| Raloxifene Hcl | Raloxifene Hcl | 47 | suppressed |
| Ranolazine Er | Ranolazine | 47 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | suppressed |
| Valproic Acid | Valproic Acid | 47 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 46 | suppressed |
| Lansoprazole | Lansoprazole | 46 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 45 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 20 |
| Humulin R | Insulin Regular, Human | 43 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 43 | suppressed |
| Nystatin | Nystatin | 43 | 28 |
| Prazosin Hcl | Prazosin Hcl | 43 | suppressed |
| Mupirocin | Mupirocin | 41 | 23 |
| Ozempic | Semaglutide | 41 | suppressed |
| Roflumilast | Roflumilast | 41 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 40 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 39 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Nadolol | Nadolol | 38 | suppressed |
| Carbamazepine | Carbamazepine | 37 | suppressed |
| Scopolamine | Scopolamine | 37 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 33 | suppressed |
| Novolin R | Insulin Regular, Human | 33 | suppressed |
| Amantadine | Amantadine Hcl | 32 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 31 | 15 |
| Vraylar | Cariprazine Hcl | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 30 | suppressed |
| Armour Thyroid | Thyroid,pork | 29 | suppressed |
| Letrozole | Letrozole | 29 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 29 | suppressed |
| Methylprednisolone | Methylprednisolone | 29 | 28 |
| Fentanyl | Fentanyl | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Otezla | Apremilast | 28 | suppressed |
| Procrit | Epoetin Alfa | 28 | suppressed |
| Insulin Lispro | Insulin Lispro | 27 | suppressed |
| Ketoconazole | Ketoconazole | 27 | suppressed |
| Lubiprostone | Lubiprostone | 27 | suppressed |
| Methotrexate | Methotrexate Sodium | 27 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 26 | suppressed |
| Insulin Aspart | Insulin Aspart | 26 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 26 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 26 | 19 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 25 | suppressed |
| Nystop | Nystatin | 25 | 13 |
| Novolog | Insulin Aspart | 24 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 23 | suppressed |
| Temazepam | Temazepam | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 21 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 20 | suppressed |
| Daptomycin | Daptomycin | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Methadone Hcl | Methadone Hcl | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 16 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Calcium Acetate | Calcium Acetate | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 19 | suppressed |
| Atenolol | Atenolol | 18 | suppressed |
| Cefdinir | Cefdinir | 18 | 15 |
| Cyclophosphamide | Cyclophosphamide | 18 | suppressed |
| Dofetilide | Dofetilide | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Indapamide | Indapamide | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Sulindac | Sulindac | 18 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 18 | 12 |
| Dayvigo | Lemborexant | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Levemir | Insulin Detemir | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 15 |
| Naltrexone Hcl | Naltrexone Hcl | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 16 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 15 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 14 | 11 |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Silodosin | Silodosin | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Mirabegron Er | Mirabegron | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 12 | suppressed |
| Zaleplon | Zaleplon | 12 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Exelon | Rivastigmine | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | 11 |
| Retacrit | Epoetin Alfa-Epbx | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.96 · 1 records | AstraZeneca Pharmaceuticals LP | FARXIGA | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error